Design Therapeutics, Inc.

NasdaqGS:DSGN 株式レポート

時価総額:US$310.3m

Design Therapeutics 将来の成長

Future 基準チェック /06

Design Therapeuticsの収益は年間17.7%で減少すると予測されていますが、年間収益は年間91.5%で増加すると予想されています。EPS は年間15%で減少すると予想されています。

主要情報

-17.7%

収益成長率

-15.0%

EPS成長率

Biotechs 収益成長28.4%
収益成長率91.5%
将来の株主資本利益率n/a
アナリストカバレッジ

Low

最終更新日08 Nov 2024

今後の成長に関する最新情報

Recent updates

Design Therapeutics (NASDAQ:DSGN) Is In A Good Position To Deliver On Growth Plans

Oct 04
Design Therapeutics (NASDAQ:DSGN) Is In A Good Position To Deliver On Growth Plans

Companies Like Design Therapeutics (NASDAQ:DSGN) Are In A Position To Invest In Growth

Jun 19
Companies Like Design Therapeutics (NASDAQ:DSGN) Are In A Position To Invest In Growth

Design Therapeutics (NASDAQ:DSGN) Is In A Good Position To Deliver On Growth Plans

Mar 15
Design Therapeutics (NASDAQ:DSGN) Is In A Good Position To Deliver On Growth Plans

Companies Like Design Therapeutics (NASDAQ:DSGN) Are In A Position To Invest In Growth

Nov 16
Companies Like Design Therapeutics (NASDAQ:DSGN) Are In A Position To Invest In Growth

Here's Why We're Not Too Worried About Design Therapeutics' (NASDAQ:DSGN) Cash Burn Situation

Jun 06
Here's Why We're Not Too Worried About Design Therapeutics' (NASDAQ:DSGN) Cash Burn Situation

Design Therapeutics (NASDAQ:DSGN) Is In A Good Position To Deliver On Growth Plans

Feb 09
Design Therapeutics (NASDAQ:DSGN) Is In A Good Position To Deliver On Growth Plans

Companies Like Design Therapeutics (NASDAQ:DSGN) Are In A Position To Invest In Growth

Oct 25
Companies Like Design Therapeutics (NASDAQ:DSGN) Are In A Position To Invest In Growth

Design Therapeutics GAAP EPS of -$0.27 misses by $0.02

Aug 08

We're Not Very Worried About Design Therapeutics' (NASDAQ:DSGN) Cash Burn Rate

Jul 02
We're Not Very Worried About Design Therapeutics' (NASDAQ:DSGN) Cash Burn Rate

Companies Like Design Therapeutics (NASDAQ:DSGN) Are In A Position To Invest In Growth

Mar 18
Companies Like Design Therapeutics (NASDAQ:DSGN) Are In A Position To Invest In Growth

Companies Like Design Therapeutics (NASDAQ:DSGN) Are In A Position To Invest In Growth

Dec 03
Companies Like Design Therapeutics (NASDAQ:DSGN) Are In A Position To Invest In Growth

Here's Why We're Not Too Worried About Design Therapeutics' (NASDAQ:DSGN) Cash Burn Situation

Aug 18
Here's Why We're Not Too Worried About Design Therapeutics' (NASDAQ:DSGN) Cash Burn Situation

Design Therapeutics expands board of directors

Jun 07

Design Therapeutics EPS misses by $0.24

May 10

業績と収益の成長予測

NasdaqGS:DSGN - アナリストの将来予測と過去の財務データ ( )USD Millions
日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数
12/31/2026N/A-79N/AN/A3
12/31/2025N/A-67N/AN/A3
12/31/2024N/A-52N/AN/A3
9/30/2024N/A-48-46-46N/A
6/30/2024N/A-51-51-51N/A
3/31/2024N/A-59-54-54N/A
12/31/2023N/A-67-59-59N/A
9/30/2023N/A-72-61-61N/A
6/30/2023N/A-74-61-60N/A
3/31/2023N/A-69-58-57N/A
12/31/2022N/A-63-52-51N/A
9/30/2022N/A-57-46-45N/A
6/30/2022N/A-51-41-40N/A
3/31/2022N/A-43-39-38N/A
12/31/2021N/A-36-31-29N/A
9/30/20210-28-24-23N/A
6/30/20210-19-17-17N/A
3/31/20210-13-10-10N/A
12/31/20200-8-9-9N/A
12/31/20191-200N/A

アナリストによる今後の成長予測

収入対貯蓄率: DSGN今後 3 年間、利益が出ない状態が続くと予測されています。

収益対市場: DSGN今後 3 年間、利益が出ない状態が続くと予測されています。

高成長収益: DSGN今後 3 年間、利益が出ない状態が続くと予測されています。

収益対市場: DSGN来年は収益がないと予測されています。

高い収益成長: DSGN来年は収益がないと予測されています。


一株当たり利益成長率予想


将来の株主資本利益率

将来のROE: DSGNの 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です


成長企業の発掘